*By Michael Teich* President Trump's top economic advisor Larry Kudlow said this week that economic growth could top [4 percent](https://www.cnbc.com/2018/07/18/trump-advisor-kudlow-says-economic-growth-could-top-4percent-for-a-quarter-.html). And while JPMorgan ETFs global market strategist Samantha Azzarello agrees, she does doubt its sustainability. "It’s like running on Red Bull, which you can not do forever," she told Cheddar in an interview Thursday. The economy is getting a jolt from tax cuts, government spending, and high consumption. But trade tensions have weighed on the markets recently, and as Azzarello explained, we're late in the cycleーthe bull market turned 9 years old in March, its longest ever run. "There's fatigue with this bull market, which is bizarre. We should feel good that the earnings growth is so good," she said. "If you contrast the earnings data, which is so positive and so strong, with how much the market is up, it literally doesn't make any sense." For the full segment, [click here.](https://cheddar.com/videos/u-s-economy-running-on-red-bull-but-wont-last-says-market-strategist)

Share:
More In Business
Need2know: War Crimes, Sacramento Shooting Arrest & Aluminum Shortages
Catching you up on what you need to know on April 5, 2022, with Biden's call for a war crimes trial for Putin, another arrest made in the Sacramento mass shooting, NYC rolling out a campaign against Florida’s "Don’t Say Gay" bill, an aluminum shortage potentially affecting beer and cat food cans, and more.
Tax Day is Two Weeks Away — Here's What You Need to Know if You're a Retail or Crypto Investor
Filing your taxes should be easy and straightforward if your documents are together — but what about if you became a new cryptocurrency or retail investor? What if you worked remotely last year, and not in the same state as your employer? What if you received a pandemic stimulus check, or are eligible for the child tax credit? Luis Rivero, CPA and Director of Tax at Taxfyle, joins Closing Bell to discuss what exactly all taxpayers need to know, whether they hold crypto investments, worked out of state, have children, and more.
RedHill Biopharma Has Two COVID-19 Drugs in Clinical Trials In Hopes Of Making More Treatments Available
Two years after the pandemic began, vaccines are widespread, but COVID-19 treatments aren't as plentiful. RedHill Biopharma is working to change that with its easy-to-take coronavirus treatments — which come in pill form and treat cases ranging from mild to severe. Guy Goldberg, Chief Business Officer at RedHill Biopharma, joins Closing Bell to discuss the company's two COVID-19 treatments in trial, pricing once the drugs are widely available, the company's latest earnings results, and more.
Load More